Heart surgery sedative may shield your memory
NCT ID NCT06655025
First seen Jun 24, 2026 · Last updated Jun 24, 2026
Summary
This study tested whether giving the sedative dexmedetomidine during open heart surgery can help protect patients' thinking and memory afterward. Researchers measured brain function with a simple test and checked a blood marker of brain injury. The trial included 32 adults having elective open heart surgery, and results may show whether this drug reduces cognitive decline.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC SURGERY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sohag University
Sohag, Egypt
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Dexmedetomidine (a sedative drug given during surgery)
What this could lead to
If it works, this could point toward a simple way to protect thinking and memory after open heart surgery.
What could go wrong
This is a very small, completed trial with only 32 patients. Results may not apply to everyone, and the drug can cause slow heart rate or low blood pressure.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.